ArticleCureus2026
Hemorrhagic Rupture of a Hepatic Adenoma in a Postmenopausal Female: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic adenoma (HA) is a rare benign liver lesion most commonly observed in females of reproductive age using oral contraceptive pills (OCPs). Though typically asymptomatic, HA may lead to complications such as hemorrhage or malignant transformation. Current literature highlights an increased risk of hemorrhage in larger lesions among premenopausal females and transformation to hepatocellular carcinoma in postmenopausal females. This report discusses a case of a 58-year-old postmenopausal female who presented with a sudden onset of back pain, syncope, nausea, and vomiting. CT imaging revealed moderate- to large-volume intraperitoneal fluid concerning for hemoperitoneum and a right hepatic mass, prompting urgent surgical intervention. The patient was ultimately diagnosed with a hemorrhagic rupture of a 3.8-cm HA. Postoperatively, the patient was advised to discontinue OCP use and undergo repeat imaging in three months. Subsequent scans revealed a minor increase in size and a slight elevation in alpha-fetoprotein. The patient has been referred to oncology for further recommendations. This case aims to increase recognition of HA complications, specifically hemorrhage as a potentially fatal presentation, which can present atypically, even in postmenopausal patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.